Legal News

EMA adopts reflection paper on AI/ML in drug development

Published on: 02 October 2024
Published by LNB News

LNB News 02/10/2024

Document Information

Issue Date: 02 October 2024

Published Date: 02 October 2024

Jurisdiction(s): European Union

Article summary

The European Medicines Agency (EMA) has adopted a reflection paper on using AI and machine learning (ML) in drug development after considering extensive feedback during the consultation period with revision to key parts. The updated paper also includes changes based on the recent EU AI Act.

Popular documents